Stay updated with breaking news from Pooja tidke. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Regulating online gaming for user safety financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
While such programming don’t technically follow Indian codes and ethics, platforms sign contracts to edit and modify content to suit the tastes of Indian audiences, much like practices followed for censoring Hollywood films when released theatrically in India. ....
I. Introduction On 25th April 2023, 3 of 5 Judges of the Hon ble Supreme Court of India rendered a judgment holding that: an instrument which is eligible to stamp duty may contain an arbitration. | May 4, 2023 ....
Court rejects Cutis Biotech plea against Serum Institute claiming its trademark Covishield ANI | Updated: Jan 30, 2021 23:13 IST Pune (Maharashtra) [India], January 30 (ANI): A civil court in Pune rejected the injunction application filed on behalf of CUTIS Biotech against Serum Institute of India (SII), claiming trademark Covishield of the Covid-19 vaccine, on Saturday. According to SII s press release, earlier this month, Cutis-Biotech, a pharmaceutical products manufacturer and seller based in Maharashtra, filed a suit in the civil court seeking to restrain SII from using the trademark Covishield or any other similar names for its COVID-19 vaccine and claimed the pharma firm is a prior user of the brand name. ....
Pune court rejects injunction against SII over Covishield trademark By IANS | Published on Sat, Jan 30 2021 22:48 IST | 0 Views
B desh to receive 2 mn Covishield doses from India as gift (Photo: Kuntal Chakrabarty/IANS). Image Source: IANS News New Delhi, Jan 30 : A civil court in Pune on Saturday rejected an injunction application filed on behalf of pharmaceutical company Cutis Biotech against the Serum Institute of India, seeking the latter to restrain from using the trademark Covishield for its Covid-19 vaccine. Earlier this month, Cutis-Biotech, a pharmaceutical products manufacturer and seller based in Maharashtra, had filed a suit in the civil court seeking to restrain SII from using the trademark Covishield or any other similar names for its Covid-19 vaccine, claiming that the pharma company is a prior user of the brand name. ....